Biolidics expects 'strong interest' in share placement
Add BT as a preferred sourceSingapore
CANCER diagnostics company Biolidics is expecting "strong interest" for its share placement that could raise some S$3.1 million to fuel its business expansion and pursue new growth opportunities.
"While the current market conditions are choppy, we are encouraged that Biolidics' share placement exercise has attracted strong interest and we look forward to accelerating our plans to enable greater market outreach and accessibility to our pipe-line of diagnostic solutions," Biolidics' non-executive and non-independent chairman Jeremy Yee told BT on Monday.
TRENDING NOW
Frasers Property-led consortium outbids two others with S$2.13 billion offer for Bayshore Drive mixed-use site
GovTech retrenches 93 staff in first phase of agency’s 2-year workforce transformation
A new kind of ‘ceasefire’ between US and Iran where talks, strikes are part of the same process
Philippines’ income upgrade hides grim reality for most Filipinos
